Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R Edwards

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Therapie|March 7, 2002
The management of adverse drug reactions: from diagnosis to signalI R Edwards
British Journal of Clinical Pharmacology|July 27, 1999
Spontaneous reporting--of what? Clinical concerns about drugsI R Edwards
Annals of the Academy of Medicine, Singapore|January 1, 1993
Drug safety monitoring: an international perspectiveI R Edwards
The Journal of Rheumatology|May 22, 2001
The WHO Programme for International Drug Monitoring, its database, and the technical support of the Uppsala Monitoring CenterM Lindquist, I R Edwards
European Journal of Clinical Pharmacology|April 1, 1980
Once-daily dosing of timolol in hypertension: a controlled studyI R Edwards, O Else
Pharmacoepidemiology and Drug Safety|January 1, 1997
Reasons for reporting adverse drug reactions--some thoughts based on an international reviewC Biriell, I R Edwards
The New Zealand Medical Journal|June 28, 1989
A safety profile of controlled release naproxen tabletsB Allen, I R Edwards
Lancet (London, England)|October 24, 1992
Reporting side-effectsM Lindquist, I R Edwards
The Central African Journal of Medicine|December 1, 1980
Glucose insulin potassium (GIK) in treatment of congestive cardiomyopathyT Gwata, I R Edwards
Drug Safety|November 14, 1997
The challenge of effectively communicating risk-benefit informationI R Edwards, B Hugman
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Therapie|March 7, 2002
The management of adverse drug reactions: from diagnosis to signalI R Edwards
British Journal of Clinical Pharmacology|July 27, 1999
Spontaneous reporting--of what? Clinical concerns about drugsI R Edwards
Annals of the Academy of Medicine, Singapore|January 1, 1993
Drug safety monitoring: an international perspectiveI R Edwards
The Journal of Rheumatology|May 22, 2001
The WHO Programme for International Drug Monitoring, its database, and the technical support of the Uppsala Monitoring CenterM Lindquist, I R Edwards
European Journal of Clinical Pharmacology|April 1, 1980
Once-daily dosing of timolol in hypertension: a controlled studyI R Edwards, O Else
Pharmacoepidemiology and Drug Safety|January 1, 1997
Reasons for reporting adverse drug reactions--some thoughts based on an international reviewC Biriell, I R Edwards
The New Zealand Medical Journal|June 28, 1989
A safety profile of controlled release naproxen tabletsB Allen, I R Edwards
Lancet (London, England)|October 24, 1992
Reporting side-effectsM Lindquist, I R Edwards
The Central African Journal of Medicine|December 1, 1980
Glucose insulin potassium (GIK) in treatment of congestive cardiomyopathyT Gwata, I R Edwards
Drug Safety|November 14, 1997
The challenge of effectively communicating risk-benefit informationI R Edwards, B Hugman
Pageof 12